Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
Integrin-independent support of cancer drug resistance by tetraspanin CD151
Soonyean Hwang1, Takayuki Takimoto1,2, Martin E Hemler3
1Department of Cancer Immunology and Virology, Rm SM-520C, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.
Abstract:
Tetraspanin protein CD151 has typically been studied as binding partner and functional regulator of laminin-binding integrins. However, we show here that CD151 supports anti-cancer drug resistance independent of integrins. CD151 ablation sensitized multiple tumor cell types to several anti-cancer drugs (e.g., gefitinib and camptothecin), thus increasing apoptosis, as seen using cleaved caspase-3, cleaved PARP (poly (ADP-ribose) polymerase), annexin V, and propidium iodide staining assays. Drug sensitization due to CD151 ablation is integrin-independent, because, (1) effects occurred in cells when integrins were unengaged with ligand, (2) integrin ablation (α3 and α6 subunits) did not mimic effects of CD151 ablation, (3) the CD151QRD mutant, with diminished integrin association, and CD151WT (unmutated CD151) similarly reconstituted drug protection, and (4) treatment with anti-cancer drugs selectively upregulated intracellular nonintegrin-associated CD151 (NIA-CD151), consistent with its role in drug resistance. Together, these results suggest that upregulated CD151 expression may support not only typical integrin-dependent functions, but also integrin-independent survival of circulating (and possibly metastatic) cancer cells during anti-cancer drug therapy.
Insights
Tetraspanin CD151 promotes cancer drug resistance independently of integrins. Ablating CD151 sensitizes tumor cells to chemotherapy, increasing apoptosis and suggesting a new therapeutic target for overcoming drug resistance.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Tetraspanin CD151 is known to regulate integrin functions.
- Its role in cancer drug resistance has not been fully elucidated, particularly independent of integrins.
Purpose of the Study:
- To investigate the role of CD151 in anti-cancer drug resistance.
- To determine if CD151's function in drug resistance is dependent on integrin interactions.
Main Methods:
- CD151 ablation in multiple tumor cell types.
- Treatment with anti-cancer drugs (gefitinib, camptothecin).
- Apoptosis assays including cleaved caspase-3, cleaved PARP, annexin V, and propidium iodide staining.
- Analysis of integrin-dependent and -independent CD151 functions using integrin-deficient cells and CD151 mutants.
Main Results:
- CD151 ablation sensitized tumor cells to multiple anti-cancer drugs, increasing apoptosis.
- This drug sensitization was independent of integrin engagement or ablation.
- A CD151 mutant with diminished integrin association retained the ability to confer drug protection.
- Anti-cancer drug treatment upregulated intracellular nonintegrin-associated CD151 (NIA-CD151).
Conclusions:
- CD151 plays a significant role in supporting anti-cancer drug resistance through an integrin-independent mechanism.
- Upregulated CD151 may enhance the survival of circulating and metastatic cancer cells during therapy.
- Targeting CD151 could be a strategy to overcome drug resistance in cancer treatment.
More Related Videos
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Treatment Resistant Cancers
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Introduction to Test of Independence
The test statistic for a test of independence is similar to that of a goodness-of-fit test:
Hypothesis Test for Test of Independence
H0: The two variables (factors)...
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...